Home › Hypertrophic Cardiomyopathy › Massachusetts › Boston
Hypertrophic Cardiomyopathy clinical trials in Boston, MA
6 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RecruitingObservational study
- Harvard (Massachusetts General Hospital), Boston
- Harvard Medical School - Brigham and Women's Hospital (BWH), Boston
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
RecruitingObservational studyHealthy volunteers welcome
- Tufts Medical Center, Boston
- Boston Medical Center, Boston
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
RecruitingPhase 2
- Imbria Investigational Site, Boston
A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
RecruitingPhase 2
- Boston Children's Hospital, Boston
HCMR Re-Imaging Study
RecruitingObservational study
- Brigham & Women's Hospital, Boston
Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
RecruitingObservational study
- Analysis Group Inc., Boston
Hypertrophic Cardiomyopathy trials in other cities
- Cleveland, OH4 studies
- San Francisco, CA4 studies
- Charlottesville, VA4 studies
- Chicago, IL3 studies
- New York City, NY3 studies
- Plano, TX3 studies
- Charlotte, NC3 studies
- Houston, TX3 studies
- San Diego, CA3 studies
Other studies in Boston
- Breast Cancer112 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)85 studies
- Metastatic Cancer63 studies
- Colorectal Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.